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The protective effects of glutathione monoester (GME) on buthionine sulfoximine (BSO)-induced glutathione (GSH) depletion and its
sequel were evaluated in rat erythrocyte/erythrocyte membrane. Animals were divided into three groups (n = 6 in each): control, BSO and
BSO+GME group. Administration of BSO, at a concentration of 4 mmol/kg bw, to the albino rats resulted in depletion of blood GSH level
to about 59%. GSH was elevated several folds in the GME group as compared to the control (P< 0.05) and BSO (P< 0.001) groups.
Decreased concentration of vitamin E was found in the erythrocyte membrane isolated from BSO-administered animals. Antioxidant
enzymes, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPX) were also found to be altered due to BSO-induced
GSH depletion in blood erythrocytes. The SOD and CAT activities in BSO group were significantly lower (P < 0.001) than the other groups.
Lipid peroxidation index and malondialdehyde (MDA) levels in erythrocytes and their membranes were increased to about 45% and 40%,
respectively. The activities of Ca2 +ATPase, Mg2 +ATPase and Na+K+ATPase were lower than those of control group (P< 0.05), whereas the
activities of these enzymes were found to be restored to normal followed by GME therapy (P < 0.05). Cholesterol, phospholipid and C/P ratio
and some of the phospholipid classes like phosphatidylcholine (PC), lysophosphatidylcholine (LPC) and sphingomyelin were significantly
(P < 0.05) altered in the erythrocyte membranes of BSO-administered rats compared with those of control group. These parameters were
restored to control group levels in GME-treated group. Oxidative stress may play a major role in the BSO-mediated gamma glutamyl cysteine
synthetase (g-GCS) inhibition and hence the depletion of GSH. In conclusion, our findings have shown that antioxidant status decreased and
lipid peroxidation increased in BSO-treated rats. GME potentiates the RBC and blood antioxidant defense mechanisms and decreases lipid
peroxidation.
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1. Introduction the cytotoxic effects of BSO on liver [4] and LDL oxidationThe clinical use of buthionine sulfoximine (BSO) during
chemo- and radiotherapy against drug and radiation resistant
tumors has been practiced in the recent years [1,2]. For
instance, the exposure of cells and tissues to BSO elicits a
number of effects including hepatic dysfunction, renal
calcification, LDL oxidation, etc. Studies by Meister’s
group have demonstrated the toxic effects of BSO in vivo
and in vitro [3]. Recent studies from our laboratory revealed0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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The vital role of structural modification in sulfhydryl
groups in protein has demonstrated in abnormal cellular
functions, including transport of organic cations [5,6].
Glutathione (GSH), a tripeptide, the major non-protein thiol
in mammalian cells, performs various functions ranging
from cellular metabolism to transport and also protection
against oxygen free radicals [7,8]. It has been reported that
alteration of endogenous GSH is associated with mitogenic
stimulation and GSH may regulate DNA synthesis. GSH
depletion decreases the rate of cell proliferation and inhibits
cancer growth [9]. It has also been reported that chemical
depletion of intracellular GSH resulted in a decline of
cellular pH in Ehrlich tumor cells, possibly due to changes
in the Na+/H+ antiporter activity [10]. Another study indi-
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of neutrophil function as measured by decrease in superox-
ide generation, Na+ and Ca+ influx and lysosomal enzyme
release [11].
Lipids are involved in a wide spectrum of cellular
functions. Studies have shown changes in cholesterol and
phospholipid pattern associated with malignancy and cell
differentiation [12–14]. Our recent studies with BSO have
also demonstrated the increased levels of lysophosphatidyl-
choline (LPC) with corresponding decrease in phosphati-
dylcholine (PC) of oxidatively modified LDL (unpublished
data). We have also observed a decrease in the cellular GSH
associated with oxidation of lipids and proteins (apo-B) of
rat LDL in vivo. In view of this, we investigated the effect
of BSO on the erythrocytes and their membranes that are
always exposed to high partial pressure of oxygen.
In light of the above, the optimal use of BSO to sensitize
the resistant tumor cells requires a detailed knowledge on its
effects to the normal cells and it is also important to design
the protocols to protect the normal cells and macromole-
cules from oxidative damages. Erythrocyte membranes are
very rich in polyunsaturated fatty acids (PUFA) and are
more vulnerable to lipid peroxidation due to constant
exposure to oxygen. In the present study we have depleted
GSH content using BSO and its effects were investigated.
Therapeutic trials were also made with glutathione mono-
ester (GME) supplementation to the BSO-treated animals.2. Materials and methods
2.1. Chemicals
All the fine chemicals including BSO, bovine serum
albumin (BSA), reduced glutathione (GSH), oxidised glu-
tathione (GSSG), dithionitrobenzoic acid (DTNB), bath-
ophenanthroline, etc., were purchased from Sigma
Chemical Co. USA. All other chemicals used were of good
quality and analytical grade.
2.2. Animals
Male albino Wistar rats (100F 10 g body weight)
purchased from Fredrick Institute of Plant Protection and
Environmental Toxicology (FIPPET), Padappai, Chennai,
were fed ad libitum chow containing 5% fat, 21% protein,
55% nitrogen free extract, 4% fiber (w/w) and adequate
mineral and vitamin contents.
2.3. Experimental design
The rats were divided into three groups; each group
consisted of six animals.
Group I: (Control) Rats were given physiological saline
(0.5 ml) intraperitoneally (i.p.) twice a day.Group II: (BSO) Rats were intraperitoneally given BSO
(0.5 ml, 4 mmol/kg body weight) twice a day.
The dosage was fixed on the basis of Meister’s
report [3].
Group III: (BSO+GME) Intraperitoneal injection of BSO
(0.5 ml, 4 mmol/kg body weight) twice a day.
GSH-monoester (5 mmol/kg body weight)
injection (0.5 ml) was given 30–45 min after
BSO administration based on Meister’s report
[3].
2.4. Isolation of erythrocytes and erythrocyte membranes
Erythrocytes and their membranes were isolated from
control and experimental groups according to the method
of Dodge et al. [15] with slight modifications. Packed
cells were washed with isotonic saline to remove the
buffy coat. Different aliquots of packed cells were thor-
oughly washed with tris-buffer, 0.31 M, pH 7.4. These
were used for the determination of several biochemical
parameters. Then the another aliquot of packed cells was
subjected to hemolysis by adding hypotonic tris-buffer,
0.015 M, pH 7.2. After 4–6 h, the erythrocyte ghosts
were sedimented by high speed centrifugation at 12000
rpm, for 40–45 min, at 4–6 jC. The supernatant,
hemolysate, was used for the analysis of antioxidants.
The erythrocyte membrane pellets were suspended in 0.02
M tris-buffer, pH 7.2, and subjected to various biochem-
ical investigations.
2.5. Estimation of protein
The protein content of the erythrocyte membranes was
estimated according to the method of Lowry et al. [16].
2.6. Determination of antioxidants
2.6.1. Glutathione estimation
GSH was estimated from the hemolysate after sediment-
ing the erythrocyte membrane (EM) fraction. An aliquot of
lysate was subjected to assay with DTNB and the color
produced was read immediately at 412 nm [17].
2.6.2. a-Tocopherol estimation
Erythrocyte membrane content of a-tocopherol was
determined after extracting with hexane. The hexane
extracts were processed according to the method of Desai
[18] using bathophenanthroline, which forms complex with
ferrous ions.
2.7. Determination of antioxidant enzymes
2.7.1. Catalase (CAT)
CAT activity of erythrocytes was assayed following the
method of Beers and Seizer [19]. The breakdown of
hydrogen peroxide on addition of enzyme source was
Table 1
Effect of BSO and BSO+GME treatment on the levels of antioxidants in
blood and erythrocyte membrane of rat
Parameter Control BSO BSO+GME
Hemolysate total
GSH (Amol/g Hb)
9.87F 0.68a 4.29F 0.62b 9.41F1.46a
a-Tocopherol (EM)
(Ag/mg Protein)
2.56F 0.23a 1.42F 0.12b 2.48F 0.11a
Catalase (EM) Amol
H2O2 cons/min/mg
protein
3.21F 0.44a 1.74F 0.15b 2.51F 0.22a
Superoxide dismutase
(hemolysate,
units/mg Hb)
3.31F 0.29a 1.21F 0.34b 3.03F 0.27a
Glutathione peroxidase
(hemolysate, Amol
GSH cons./min/mg
protein)
39.87F 3.19a 28.92F 1.50b 37.53F 2.64a
Values represent the group meansF S.D. for six animals. Different
superscripts within a row show significant variations between groups,
P < 0.05.
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solution in ultraviolet (240 nm) region.
2.7.2. Superoxide dismutase (SOD)
The activity of SOD in the hemolysate was determined
according to the method of Misra and Fridovich [20]. It is
based on the inhibition of epinephrine adrenochrome tran-
sition by the enzyme.
2.7.3. Glutathione peroxidase (GPX)
Activity of GPX from hemolysate was assayed accord-
ing to the procedure of Rotruck et al. [21] with slight
modifications. This procedure is based on the reaction
between the glutathione remaining in the following reaction
with DTNB to form a compound which absorb light
maximally at 412 nm.
2GSHþ H2O2!GPx GSSG þ 2H2O
2.8. Determination of lipid peroxides by high performance
liquid chromatography (HPLC)
Lipid peroxides were measured as malondialdehyde
(MDA) products, using the HPLC acetonitrile precipitation
assay [22]. Briefly, aliquots of erythrocytes and membranes
suspended in buffer were mixed with equal volume of
acetonitrile, homogenized and centrifuged to precipitate
the proteins. The supernatants were then filtered through
millipore membrane (0.2 Am) and 20 Al of samples was
injected by Hamilton syringe in the HPLC for detection of
MDA. The MDAwas identified by comparing the retention
time (Rt) with the standards, tetra methoxy propane run
under identical conditions. Diene conjugates, indices of
LPO initiation, were measured in the lipid extracts of
erythrocyte membranes by following the method of Klein
[23].
2.9. Determination of membrane-bound ATPases
Activities of Na+K+, Ca2 + and Mg2 + ATPases from
erythrocyte membranes were determined by following the
method of Bonting [24], Hjerten and Pan [25] and Ohinishi
et al. [26], respectively. The activities were indirectly
measured by estimating the phosphorous liberated after
the incubation of EM in a reaction mixture containing the
substrate ATP with the co-substrate elements at 37 jC for 15
min. The reactions were arrested by adding 1.0 ml of 10%
TCA. The phosphorus content from the TCA supernatants
was then determined by the method of Fiske and Subbarow
[27].
2.10. Lipid extraction and analysis
The erythrocyte membrane pellets obtained from 1.0 ml
of packed cells were subjected to lipid extraction withchloroform–methanol (1:2, v/v) and purified by the method
of Folch et al. [28]. Lipid extract from 1.0-ml packed cells
was applied to a silicic acid (Sigma) column and sequential
elution of neutral, glyco- and phospholipids was done by
adding the respective solvent chloroform (10 column vol-
umes), acetone + 0.03% water (2 column volumes) and
methanol (10 column volumes). All the fractions were
collected individually and dried under nitrogen atmosphere.
Thin layers of silica gel-H with 0.5-mm thickness (used for
the purpose of quantitative analysis of phospholipids than is
generally used for qualitative analysis) were made using
TLC applicator; the plates were allowed to dry at room
temperature for 1–2 h and then activated at 110 jC for 1 h,
just before use. Samples (40 Al, from 2.0 ml of stock extract
containing phospholipids of 1.0-ml packed cells) were load-
ed on to the gel using capillary tubes. Chromatograms were
developed with chloroformmethanol con.ammonia–
water (70:30:3:2, by volume). After the run, air dried plates
were exposed to iodine vapor and the spots were detected,
marked and then the iodine was evaporated. Various frac-
tions with silica gel were scrapped off and taken in test
tubes. The silica gel was then removed by centrifugation
after adding 2.0 ml solvent to each tube. The supernatant
solvent with individual phospholipid class was subjected to
perchloric acid digestion; phosphorous content was deter-
mined by following the method of Fiske and Subbarow
[27]. Erythrocyte membrane total cholesterol [29] and total
phospholipids [30] were estimated from the lipid extract as
described.
2.11. In vitro studies with H2O2
Percentage maximal release of MDA, a product of
PUFA, was measured following incubation of erythrocytes
or membranes with two different concentrations of hydro-
Table 2
HPLC determination of MDA and conjugated dienes in erythrocytes/
membranes isolated from BSO and BSO+GME-treated rats
Parameter Control BSO BSO+GME
Erythrocytes (pmol
MDA/mg Hb)*
7.09 12.94 8.71
Percentage variation
of MDA production
compared to control
– 82.51% 22.85%
Erythrocyte membrane
(nmol MDA/
mg protein)*
1.71 2.79 1.94
Percentage variation
of MDA production
compared to control
– 63.16% 13.45%
Conjugated dienes
(A233/A215)
0.391F 0.012b 0.497F 0.014a 0.393F 0.011b
Values represent the group meansF S.D. for six animals. Different
superscripts within a row show significant variations between groups,
P < 0.05.
*Values are the average of triplicates, determined by HPLC.
Table 4
Effect of BSO and BSO+GME treatment on erythrocyte membrane lipid
profile of rat
Parameter
(Ag/mg protein)
Control BSO BSO+GME
Cholesterol 153.26F 10.88b 172.63F 5.18a 149.06F 7.73b
Phospholipids 238.61F16.24a 175.52F 12.82b 225.29F 12.08a
C/P ratio 0.64F 0.01b 0.70F 0.009a 0.66F 0.01b
Values represent the group meansF S.D. for six animals. Different
superscripts within a row show significant variations between groups.
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membrane preparation were suspended in 3.8 ml of PBS
with and without Na-azide. One milliliter of 3% H2O2 was
added to the tube containing no Na-azide and 0.75% H2O2
was added to the tube containing Na-azide. Blanks without
peroxide and reagent blank were incubated for 1 h. Then the
reaction was arrested by adding 1.0 ml of 10% TCA. TCA
supernatants were then subjected to TBARS assay by
modified double heating method of Draper and Hadley
[32]. Percent maximal MDA release was calculated as
follows,
% Maximal release
¼ MDA release ð3% H2O2Þ
MDA releaseð0:75% H2O2 þ Na azideÞ  100
2.12. Statistical analysis
Data are expressed as meanF S.D. for six animals in
each group. Statistical analysis of variance (ANOVA) and
Student–Newman–Keul multiple comparison test were
applied to determine the significant differences among the
groups. Correlation coefficients were also made betweenTable 3
In vitro studies on H2O2-induced LPO (maximal release of MDA) in erythrocytes
Source Groups Untreated cells
Erythrocyte Control 6.21F 0.09b
(pmol/mg Hb) BSO 11.16F 1.23a
BSO+GME 7.48F 0.21b
Erythrocyte membrane Control 0.92F 10.06b
(nmol/mg protein) BSO 2.11F 0.12a
BSO+GME 1.06F 0.08b
Values represent the group meansF S.D. for six animals. Different superscripts wcertain parameters. P values less than 0.05 were considered
significant [33].3. Results
3.1. Body weights
There were no statistically significant changes in the
body weights of animals noted during the study (data not
given).
3.2. Antioxidants/enzymes status
Table 1 indicates the antioxidant status of blood and
erythrocyte membranes. The level of blood glutathione
(P < 0.001) and the activities of SOD (P < 0.001) and
GPX (P < 0.01) were diminished significantly. Decreased
levels of erythrocyte membrane a-tocopherol and CAT
activity (P < 0.01) were observed in the BSO-induced
GSH-depleted rats. Administration of GME is found to
have a protective effect on the above parameters as shown
in Table 1.
3.3. Levels of MDA determined by HPLC
Elevated concentrations of MDA (P < 0.001) were
recorded in erythrocytes and erythrocyte membranes isolat-
ed from BSO-treated rats when compared to the control and
GME-supplemented groups (Table 2). BSO treatment to the
rats resulted in 82% and 63% increase in the concentration
of MDA of erythrocytes and erythrocyte membranes, re-
spectively, when compared to controls. Increased absor-and erythrocyte membranes isolated from control and experimental groups
Treated with
3% H2O2
Treated with 0.75%
H2O2 +Na-azide
%Maximal
release of MDA
6.48F 0.23b 96.28F 3.49b 6.66F 0.43b
15.29F 1.02a 112.28F 4.9a 13.6F 1.08a
6.98F 0.86b 101.81F 4.3b 6.86F 0.72b
1.08F 0.06b 3.69F 0.43b 29.27F 2.43b
3.23F 0.16a 5.62F 0.48a 57.47F 4.12a
1.16F 0.12b 3.83F 0.61b 30.29F 2.38b
ithin a column show significant variations between groups, P< 0.05.
Fig. 1. Effect of BSO and GSO+GME treatment on the activities of erythrocyte membrane-bound ATPases in rat.
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served from erythrocyte membrane (P < 0.05) in the BSO-
administered animals. The levels of TBARS and diene
conjugates were normalised in the GME-treated rats (Table
2). GME therapy to the BSO-treated animals reduced the
MDA concentration to 23% and 13% in the erythrocytes
and erythrocyte membranes, respectively, when compared to
controls (Table 2).
3.4. In vitro lipid peroxidation
Table 3 depicts the basal and H2O2-induced LPO in
erythrocytes and erythrocyte membranes obtained from
control and experimental animals, in vitro. The level of
LPO significantly increased (P < 0.05) in both the erythro-
cytes and membranes of BSO group when compared to
control. On incubation with H2O2 and Na-azide, a maxi-
mum release of MDA was recorded in thiol-depleted rats.Fig. 2. Effect of BSO and BSO+GME treatment on the leGME-supplemented rats showed the reverted levels of
membrane lipid peroxides.
3.5. Erythrocyte membrane (EM) lipid profile
The levels of cholesterol and phospholipids extracted
from BSO-administered rat erythrocyte membrane were
altered (Table 4) significantly (P < 0.01). The levels of
phospholipid had decreased in BSO-treated animals, where-
as the cholesterol and cholesterol/phospholipid ratio had
increased (P < 0.05). GME therapy to the BSO-treated
animals resulted in restoration of GSH levels and prevented
the above changes in the erythrocyte membrane.
3.6. Membrane-bound ATPases
The activities of the membrane-bound enzymes were also
found to diminish on BSO-induced GSH depletion (Fig. 1).vels of erythrocyte membrane phospholipid classes.
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(P < 0.001), Mg+ATPase (P < 0.01) and Na+K+ATPase
(P < 0.05) activities were decreased in BSO injected rats,
but they were normalized upon GME-supplementation
along with BSO (Fig. 1).
3.7. EM-phospholipid profile
Fig. 2 indicates the concentrations of phospholipid classes
in erythrocyte membrane of rats treated with BSO and
BSO+GME. Statistically significant decrease in the levels
of PC (P < 0.01) and sphingomyelin (P < 0.01) and increase
in the levels of LPC (P < 0.01) and phosphatidyl ethanol-
amine (P < 0.05) were noted in BSO-treated animals, where-
as no significant changes were seen in the levels of amino
phospholipids. GME-supplementation resulted in bringing
back all these parameters to near control values (Fig. 2).
3.8. Correlation analysis
Fig. 3 shows correlations in all the groups between (a)
GSH and TBARS, (b) GSH and vit. E, (c) vit. E and total
ATPases, and (d) C/P ratio and total ATPases. There were
negative correlations between (a) r= 0.908, P < 0.01 and
(d) r = 0.868, P < 0.05. Conversely, there were positive
correlations between (b) r = 0.987, P < 0.01 and (c) r = 0.994,
P < 0.01.Fig. 3. Correlatio4. Discussion
In general, the erythrocytes in normal physiological
conditions are resistant to oxidative damage because of their
efficient protective mechanisms. The interior of the cell is
rich in antioxidant enzymes, such as CAT, SOD, GPX and
glutathione reductase [34,35]. Erythrocyte membrane is also
rich in a-tocopherol concentration [36]. However, under
oxidative stress condition the erythrocytes may be suscep-
tible to oxidative damage due to the presence of haeme-iron,
PUFA and oxygen, which may initiate the reactions that
induce oxidative changes in red blood cells. Ney et al. [37]
had reported that erythrocytes and their membranes are very
sensitive to oxidative damage due to their content of
unsaturated fatty acids, which are continuously exposed to
high concentration of oxygen.
Our recent findings and others indicate that abnormalities
induced by BSO administration to the normal cells may be
associated with the enhanced production of reactive oxygen
species [4,38,39]. The results from the current study showed
that BSO caused a significant increase in erythrocyte and its
membrane TBARS formation, and this clearly demonstrates
that the erythrocytes are exposed to the oxidative stress
environment. It has been reported that ROS, superoxide
anions, hydroxyl radicals and hydrogen peroxide enhance
the oxidative process and induce lipid peroxidative (LPO)
damage in cell membranes and disturb the biochemical andn analysis.
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affecting membrane integrity [40–42].
In the current study, decreased levels of total GSH in the
blood of BSO-treated animals were recorded and these can
be correlated with the decreased biosynthesis of GSH by
hepatic tissues [4]. Due to the lesser availability of GSH, an
oxidative stress condition might have resulted in the circu-
latory system. Probably, this could be the reason for the
increased MDA levels recorded in the erythrocytes and their
membranes isolated from the BSO-treated rats. In general,
glutathione (GSH) is synthesized in liver and transported to
other tissues using gamma-glutamyl transpeptidase. Plasma
GSH levels arise largely from the liver; cells of the kidney
and other cells that are well equipped with transpeptidase
utilize plasma glutathione [43]. In our previous study [4], it
has been demonstrated that intraperitoneal administration of
GME to the BSO-treated rats resulted in remarkable resto-
ration of hepatic glutathione level. In accordance with this,
in the current study also GME supplementation to the GSH-
depleted rats was found to increase the blood GSH levels
tremendously, which indicates an effective uptake of GME
and transport of GSH by the liver tissue.
Another interesting observation in this study was the
decreased levels of erythrocyte membrane a-tocopherol in
the BSO group. This is well associated with the declined
GSH content and increased LPO. The decline of GSH could
be ascribed to this effect [44] and should be considered
seriously since the membranes are always rich in a-tocoph-
erol that protects them from toxic damages due to oxidative
stress.
In erythrocyte membranes, the concentrations of a-to-
copherol in diabetic rats were significantly lower than those
in control rats [45]. Vitamin E is the major lipid antioxidant
in mammalian erythrocyte membranes, where it plays an
important role in the suppression of free radical-induced
LPO [46]. The present study is well consistent with the
above and it may be proposed that the regulation of a-
tocopherol concentrations in membranes is critically impor-
tant to maintain erythrocyte membrane structure and func-
tion. Further, the decreased erythrocyte vitamin E levels can
be attributed either to increased consumption through the
destruction of oxygen-free radicals and/or to a reduction in
the regeneration of a-tocopherol from tocopheroxy radicals,
which requires GSH for the conversion [47].
Chronic administration of BSO to the rats depleted GSH
drastically and in turn resulted in the altered activities of the
antioxidant enzymes. In the present investigation, BSO
treatment decreased the activities of CAT, SOD and GPX.
It has been also seen that CAT activity was inhibited by free
radicals such as singlet oxygen and superoxide and peroxy
radicals [48,49]. In vitro studies by Gultekin et al. [50]
observed significant reduction in the activity of SOD in
erythrocytes exposed to chlorpyrifos-ethyl mediated toxici-
ty. In this study, the in vivo increase of TBARS mediated by
BSO indicates overproduction of ROS and was presumably
associated with enhanced LPO, confirming the fact that thesinglet oxygen and peroxyl radicals inhibited the activities
of CAT and SOD.
Sodium potassium ATPase (Na+K+ATPase), calcium
ATPase (Ca2 +ATPase) and magnesium ATPase (Mg2 +AT-
Pase) are responsible for the transport of Na+, K+, Ca2 +,
Mg2 +ions, respectively, across the membrane at the expense
of ATP hydrolysis [51]. The activities of these enzymes
markedly decreased (Fig. 1) in the erythrocyte membranes
isolated from BSO-treated rats. The activities of these
enzymes were found to be decreased in ethanol-intoxicated
rat erythrocyte membranes [52]. Our results are consistent
with the above findings and the decreased erythrocyte
membrane-bound enzyme activities can be attributed to
altered membrane fluidity, enhanced LPO and declined
antioxidant defense status during the course of BSO admin-
istration. Lipid peroxidation of biological membrane results
in changes in its fluidity [53] and in the activities of
membrane-bound enzymes [54,55].
Membrane stability is vital for the normal functioning of
membrane lipids and proteins, which include receptors and
enzymes. Alteration in the lipid levels disturbs the equilib-
rium of erythrocyte membrane and this affects the mainte-
nance of asymmetric ionic concentration between intra- and
extracellular matrix [56]. In the present study, the observed
increase in membrane cholesterol, decreased phospholipids
and increased C/P ratio in BSO-treated animals may be due
to impaired exchange of cholesterol and phospholipids from
the plasma and lipoproteins. It can also be stated that the
decreased levels of phospholipids might have affected the
exchange of cholesterol. An increased C/P ratio resulted due
to the alteration in the levels of cholesterol and phospholi-
pids. Changes in C/P ratio could affect the membrane
viscosity and other physical properties.
The main function of the phospholipids, particularly, PC,
is to maintain the structure of cellular membrane. In the
current investigation, interestingly, elevated LPC was noted
in the erythrocyte membrane of rats exposed to BSO treat-
ment with the corresponding decline in the levels of PC,
which suggests an impairment in esterification in thiol-
depleted condition. This change may be due to conversion
of PC to LPC. One of the pathways for PC biosynthesis is
progressive methylation of ethanolamine residue in PE using
methionine adenosyl transferase (MAT) as the methyl donor.
MAT is a thiol-dependent enzyme and it has been shown that
intraperitoneal injection of BSO in normal rats led to GSH
depletion, inhibiting MAT activity [57]. The decrease in PC
and increase in PE in BSO-treated rats may be due to
decreased availability of the methyl donor, S-adenosyl me-
thionine. All these lipid changes in BSO-treated rats were
reversed by the simultaneous treatment with GSH ester. This
demonstrates that the above alterations are due to thiol
depletion. Moreover, previous studies by Jain et al. [58]
had reported a decrease in the levels of PC in the lung and
alveolar fluid of glutathione-deficient mice. In vitro study
also demonstrates that glutathione modulation in HT-29 cells
resulted in altered concentrations of PC and LPC [59].
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cyte membranes of BSO-treated rats are more susceptible to
hydrogen peroxide attack and consequently release the
maximum amount of MDA when compared to the other
groups. In this context, it can be suggested that the red blood
cells incubated with sodium azide, an inhibitor of CAT,
resulted in higher release of TBARS in vitro, reflecting
impaired CAT activity in erythrocytes, and this also confirms
that the erythrocytes and erythrocyte membranes isolated
from BSO-treated rats were already exposed to an oxidative
environment caused by BSO-induced GSH depletion.
4.1. Antioxidant therapy
Administration of GME at a dose of 5 mmol/kg bw, i.p,
twice a day, for 30 days, to the BSO-treated rats resulted in
remarkable restoration of blood GSH levels. It has been
reported that GSH monoethylester may be used to supple-
ment cellular pools of GSH, in vitro and in vivo [60,61].
GSH monoesters are those in which the glycine carboxyl
group is esterified and they can be readily deesterified
intracellularly by esterase, into GSH and the corresponding
alcohol. Restoration of GSH has normalized the level of
vitamin E and also the antioxidant enzyme activities. The
observed increased activity of GPX in GME-supplemented
rats is due to the excess availability of GSH, which is the
substrate for GPX [62]. Although BSO administration
causes GSH depletion in both the normal and tumor cells,
therapeutic efficacy can be achieved due to their differential
requirements of GSH [3]. It is clear from the studies by
Teicher et al. [63] that external supply of GME shows high
specificity in protecting the normal tissues. In the current
study, the excess availability of GSH in circulation, upon
GME supplementation, facilitates RBCs to enrich the GSH
content, which might have prevented the LPO, accumula-
tion of H2O2, thereby protecting the antioxidant enzymes
from toxic effects due to severe oxidative stress during BSO
treatment. Since GSH efficiently reacts reversibly with thiol
groups of proteins, peptides and cysteine molecules, it can
protect the structural elements of the protein and regulate
several enzyme activities [64]. The reason for the enhanced
activities of CAT and SOD upon GME treatment may be
due to the decreased oxidative stress and LPO, which is
evident from the diminished production of MDA.
In the present study, GME supplementation resulted in
normal values in all the parameters that were altered during
the course of BSO administration. Thus, the therapeutic
advantage of GME along with BSO would be effective in
protecting the erythrocytes and their membranes from oxi-
dative stress-mediated damages. In conclusion, our results
indicate that the altered profiles of membrane cholesterol, C/
P ratio, and membrane-bound enzyme activities are well
associated with decreased vitamin E and enhanced lipid
peroxides. This study also suggests some interesting possi-
bilities, such as the increase in the levels of vitamin E by
regenerating from tocopheroxy radical upon GSH supple-mentation as one possible mechanism that might protect the
erythrocyte membranes from oxidative stress by interrupting
the LPO process.References
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